...
首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Intracerebroventricular D-Pen2, D-Pen5-enkephalin administration soon after stressor imposition influences behavioral responsivity to a subsequent stressor encounter in CD-1 mice.
【24h】

Intracerebroventricular D-Pen2, D-Pen5-enkephalin administration soon after stressor imposition influences behavioral responsivity to a subsequent stressor encounter in CD-1 mice.

机译:施加应激源后不久,脑室内D-Pen2,D-Pen5-脑啡肽的施用会影响行为响应性,进而影响CD-1小鼠随后发生的应激源。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Endogenous opioid peptide systems diminish stress-induced autonomic nervous system, neuroendocrine (hypothalamic-pituitary-adrenal axis) and behavioral responses, attenuating a collection of physiological symptoms basic to emotional and affective states. Neurogenic stressors may incite specific central changes in opioid peptide availability as well as changes in mu and delta-opioid receptor function. The present investigation evaluated the proactive influence of an intracerebroventricular injection of the opioid receptor agonist D-Pen2, D-Pen5-enkephalin (DPDPE) (0 microg, 0.005 microg, 1.0 microg or 2.5 microg) on locomotor behavior of mice following uncontrollable footshock (Shock) or novel shock chamber exposure (No Shock). It was expected that DPDPE administration following Shock on Day 1 would restore locomotor activity up to 1 week and prevent shock-associated behavior of mice encountering a brief session of footshock 18 days later. Exposure to Shock reduced horizontal locomotor and vertical locomotor (rearing) activity of mice while 2.5 microg DPDPE restored behavior. Eighteen days following Shock and DPDPE challenge, mice were exposed to either an abbreviated session of footshock (Mild Stress) or the shock chamber (Cues). Mice in the No Shock and Shock groups administered 2.5 microg DPDPE on Day 1 did not exhibit any locomotor deficits in response to Mild Stress on Day 18. Mice in the Shock group administered 0.005 microg DPDPE on Day 1, did not exhibit exaggerated rearing deficits following ensuing Mild Stressor encounter relative to mice reexposed to Cues on Day 18. Taken together, these data show that (a) footshock differentially affects rearing and locomotor activity, (b) DPDPE administration increases locomotor activity for up to 1 week following footshock and DPDPE administration, (c) reexposure to Mild Stress affects rearing and locomotor performance differently depending on previous stressor history and DPDPE dose, (d) DPDPE affords long-lasting protection to previously non-stressed mice against the deleterious effects of subsequent mild stress on locomotor activity, while a low dose of DPDE is sufficient to prevent shock-induced sensitization of rearing deficits, 18 days following original stressor and drug presentation. Finally, our investigation demonstrates that DPDPE administration alters the behavioral impact of future stressful encounters and emphasizes the importance of investigating opioid mechanisms in chronic stress disorders.
机译:内源性阿片肽系统减少了应激诱导的自主神经系统,神经内分泌(下丘脑-垂体-肾上腺轴)和行为反应,从而减弱了情绪和情感状态的基本生理症状。神经源性应激源可能会刺激阿片样物质肽可用性的特定中心变化,以及μ和δ阿片样物质受体功能的变化。本研究评估了脑室内注射阿片样物质受体激动剂D-Pen2,D-Pen5-脑啡肽(DPDPE)(0微克,0.005微克,1.0微克或2.5微克)对无法控制的足部震颤后小鼠的运动行为的影响(电击)或新型电击腔暴露(无电击)。预期在第1天休克后给予DPDPE可使运动能力恢复长达1周,并防止18天后遭遇短暂休克的小鼠的休克相关行为。暴露于电击会降低小鼠的水平运动和垂直运动(抚养)活动,而2.5微克DPDPE会恢复行为。休克和DPDPE攻击后第18天,将小鼠暴露于简短的休克(轻度应激)或休克室(提示)。无冲击的小鼠和第1天给予2.5微克DPDPE的休克组在第18天对轻度应激没有表现出任何运动功能障碍。第1天,给予0.005微克DPDPE的休克组小鼠在以下情况下未表现出过度的饲养缺陷相对于在第18天再次暴露于提示下的小鼠,随后出现轻度的Stressor遭遇。总而言之,这些数据表明(a)休克会不同程度地影响饲养和运动能力,(b)施​​用DPDPE会增加在实施休克和DPDPE后长达1周的运动能力,(c)再暴露于轻度压力会根据先前的应激史和DPDPE剂量而不同地影响饲养和运动能力,(d)DPDPE为先前未受压力的小鼠提供长期保护,免受随后的轻度压力对运动能力的有害影响,虽然低剂量的DPDE足以防止休克引起的饲养缺陷致敏,但最初的症状发生后18天药物和药物介绍。最后,我们的研究表明,DPDPE的使用改变了未来压力性相遇的行为影响,并强调了研究慢性压力性疾病中阿片类药物机制的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号